Sevoflurane

CHEMBL1200694 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
200.0 g/mol
LogP
2.8
Phase
4

Sevoflurane is a halogenated ether inhalational anesthetic that produces dose-dependent CNS depression through multiple mechanisms including potentiation of GABA-A receptors, inhibition of NMDA receptors, and modulation of two-pore domain potassium channels, used for induction and maintenance of general anesthesia. Its low blood-gas partition coefficient enables rapid onset and offset of anesthesia with smooth induction and recovery properties. It is widely used for outpatient procedures due to its favorable pharmacokinetic profile.

Molecular Weight

200.0500 g/mol

LogP

2.80

TPSA

9.20 Ų

Lipinski RO5

Pass

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

FCOC(C(F)(F)F)C(F)(F)F

InChI

InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2

Molecular Formula

C4H3F7O

HBD / HBA

- / 8

Rotatable Bonds

2

Heavy Atoms

12

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

Sevoflurane is a halogenated ether inhalational anesthetic that produces dose-dependent CNS depression through multiple mechanisms including potentiation of GABA-A receptors, inhibition of NMDA receptors, and modulation of two-pore domain potassium channels, used for induction and maintenance of general anesthesia. Its low blood-gas partition coefficient enables rapid onset and offset of anesthesia with smooth induction and recovery properties. It is widely used for outpatient procedures due to its favorable pharmacokinetic profile.

Yes, Sevoflurane is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200694. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 5206. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.